Kingworld Medicines Group Limited

SEHK:1110 Stock Report

Market Cap: HK$290.6m

Kingworld Medicines Group Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

SEHK:1110 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
17 Apr 24SellHK$509,999Shanghai Jianyi Private Equity Fund Management Co., Ltd.Company1,000,000HK$0.51

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 1110?
Owner TypeNumber of SharesOwnership Percentage
Institutions30,191,8045.09%
Employee Share Scheme32,900,0005.55%
General Public116,023,94619.6%
Individual Insiders413,984,25069.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 8 shareholders own 80.44% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
54%
Li Sheng Zhao
320,532,250HK$157.1m0.14%no data
15.2%
Lok San Chan
90,316,000HK$44.3m0.28%no data
5.55%
Kingworld Medicines Group Limited Share Award Scheme
32,900,000HK$16.1m0%no data
4.87%
Shanghai Jianyi Private Equity Fund Management Co., Ltd.
28,879,117HK$14.2m-41.8%13.0%
0.45%
Xuhua Zhou
2,676,000HK$1.3m10.8%no data
0.22%
Sinopharm Capital Shanghai Co., Ltd.
1,312,687HK$643.2k0%no data
0.042%
Jianbin Zhang
248,000HK$121.5k589%no data
0.036%
Cheuk Lam Wong
212,000HK$103.9k0%no data